About the Authors
- Florence Meyer-Losic
-
Affiliation IPSEN Innovation, IPSEN, Paris, France
- Simon P. Newman
-
Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom
- Joanna M. Day
-
Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom
- Michael J. Reed
-
† Deceased.
Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom
- Philip G. Kasprzyk
-
Affiliation Ipsen Biomeasure, IPSEN, Milford, Massachusetts, United States of America
- Atul Purohit
-
Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom
- Paul A. Foster
-
* E-mail: p.a.foster@bham.ac.uk
Affiliation Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom
Competing Interests
The authors have read the journal's policy and have the following conflicts: Florence Meyer-Losic and Philip Kasprzyk are employees of IPSEN. Atul Purohit is a consultant for IPSEN. The authors declare Sterix Ltd. as a commercial funder, funding the employment of Dr. Simon Newman, Dr. Joanna Day, and Dr. Paul Foster. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
† Deceased.
Conceived and designed the experiments: PAF AP MJR SPN. Performed the experiments: PAF FML JMD. Analyzed the data: PAF FML JMD PGK. Contributed reagents/materials/analysis tools: AP MJR PGK. Wrote the paper: PAF.